Small Pharma Performance
DMTTFDelisted Stock | USD 0.05 0.0009 1.80% |
The entity has a beta of 0.0, which indicates not very significant fluctuations relative to the market. the returns on MARKET and Small Pharma are completely uncorrelated. Small Pharma right now has a risk of 0.0%. Please validate Small Pharma accumulation distribution and period momentum indicator , to decide if Small Pharma will be following its existing price patterns.
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Over the last 90 days Small Pharma has generated negative risk-adjusted returns adding no value to investors with long positions. Despite nearly stable basic indicators, Small Pharma is not utilizing all of its potentials. The current stock price disturbance, may contribute to mid-run losses for the stockholders. ...more
Begin Period Cash Flow | 5.8 M | |
Total Cashflows From Investing Activities | -2.4 M |
Small |
Small Pharma Relative Risk vs. Return Landscape
If you would invest 5.09 in Small Pharma on August 26, 2024 and sell it today you would earn a total of 0.00 from holding Small Pharma or generate 0.0% return on investment over 90 days. Small Pharma is currently producing negative expected returns and takes up 0.0% volatility of returns over 90 trading days. Put another way, 0% of traded otc stocks are less volatile than Small, and 99% of all traded equity instruments are likely to generate higher returns over the next 90 trading days. Expected Return |
Risk |
Small Pharma Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Small Pharma's investment risk. Standard deviation is the most common way to measure market volatility of otc stocks, such as Small Pharma, and traders can use it to determine the average amount a Small Pharma's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0
Best Portfolio | Best Equity | |||
Good Returns | ||||
Average Returns | ||||
Small Returns | ||||
Cash | Small Risk | Average Risk | High Risk | Huge Risk |
DMTTF |
Based on monthly moving average Small Pharma is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Small Pharma by adding Small Pharma to a well-diversified portfolio.
Small Pharma Fundamentals Growth
Small OTC Stock prices reflect investors' perceptions of the future prospects and financial health of Small Pharma, and Small Pharma fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Small OTC Stock performance.
Return On Equity | -0.78 | |||
Return On Asset | -0.41 | |||
Current Valuation | 24.67 M | |||
Shares Outstanding | 321.56 M | |||
Price To Book | 1.15 X | |||
Price To Sales | 69,846 X | |||
EBITDA | (22.47 M) | |||
Cash And Equivalents | 27.15 M | |||
Cash Per Share | 0.08 X | |||
Book Value Per Share | 0.06 X | |||
Cash Flow From Operations | (16.23 M) | |||
Earnings Per Share | (0.06) X | |||
Total Asset | 45.57 M | |||
About Small Pharma Performance
By analyzing Small Pharma's fundamental ratios, stakeholders can gain valuable insights into Small Pharma's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Small Pharma has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Small Pharma has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Small Pharma Inc., a biotechnology company, focuses on developing short-acting psychedelics with therapy for the treatment of mental health conditions. The company was incorporated in 2015 and is headquartered in London, the United Kingdom. Small Pharma is traded on OTC Exchange in the United States.Things to note about Small Pharma performance evaluation
Checking the ongoing alerts about Small Pharma for important developments is a great way to find new opportunities for your next move. OTC Stock alerts and notifications screener for Small Pharma help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.Small Pharma is not yet fully synchronised with the market data | |
Small Pharma has some characteristics of a very speculative penny stock | |
Small Pharma has a very high chance of going through financial distress in the upcoming years | |
Net Loss for the year was (22.27 M) with profit before overhead, payroll, taxes, and interest of 45 K. | |
Small Pharma has accumulated about 27.15 M in cash with (16.23 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.08, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
Roughly 31.0% of the company shares are held by company insiders |
- Analyzing Small Pharma's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Small Pharma's stock is overvalued or undervalued compared to its peers.
- Examining Small Pharma's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Small Pharma's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Small Pharma's management team can help you assess the OTC Stock's leadership.
- Pay attention to analyst opinions and ratings of Small Pharma's otc stock. These opinions can provide insight into Small Pharma's potential for growth and whether the stock is currently undervalued or overvalued.
Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any otc stock could be closely tied with the direction of predictive economic indicators such as signals in estimate. You can also try the Top Crypto Exchanges module to search and analyze digital assets across top global cryptocurrency exchanges.
Other Consideration for investing in Small OTC Stock
If you are still planning to invest in Small Pharma check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Small Pharma's history and understand the potential risks before investing.
Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
Stocks Directory Find actively traded stocks across global markets | |
My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets |